| Literature DB >> 21713021 |
Mercy M Ackumey1, Cynthia Kwakye-Maclean, Edwin O Ampadu, Don de Savigny, Mitchell G Weiss.
Abstract
BACKGROUND: Buruli ulcer (BU), caused by Mycobacterium ulcerans infection, is a debilitating disease of the skin and underlying tissue. The first phase of a BU prevention and treatment programme (BUPaT) was initiated from 2005-2008, in the Ga-West and Ga-South municipalities in Ghana to increase access to BU treatment and to improve early case detection and case management. This paper assesses achievements of the BUPaT programme and lessons learnt. It also considers the impact of the programme on broader interests of the health system.Entities:
Mesh:
Year: 2011 PMID: 21713021 PMCID: PMC3119641 DOI: 10.1371/journal.pntd.0001187
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Timeline of Buruli ulcer programmes and activities in Ghana.
| Dates and References | |
| 1971 | First case of BU identified in a patient from the Ga district |
| 1989 | 96 cases of Buruli ulcer infection were discovered in the Asante Akim North District in the Ashanti Region of Ghana. |
| 1993 | A passive surveillance system for reporting Buruli ulcer was initiated in Ghana by the Ministry of Health. |
| July 1998 | Signing of the Yamoussoukro declaration on Buruli ulcer in Yamoussoukro, La Côte d'Ivoire, by the Director-General of the WHO and Heads of State of Ghana, Benin and Côte d'Ivoire. These governments agreed to mobilise resources to establish national Buruli ulcer control programmes, conduct epidemiological surveys on BU and establish surveillance systems with technical support from the WHO. |
| June-July 1999 | The Ghana Ministry of Health conducted a national case search on BU in the entire country. A total of 5,619 persons were identified with BU lesions at various stages in all 10 regions of the country. The national prevalence rate was computed as 20.7/100,000 and the Ga-district prevalence rate was 87.7/100,000 for active lesions. |
| 2002 | The establishment of the Ghana National Buruli ulcer Control Programme in accordance with the Yamoussoukro declaration. |
| July – August 2005 | Community-based study on knowledge, attitude and practice of Buruli ulcer conducted in the Ga-West district of Ghana. |
| 2005 | Buruli ulcer Prevention and Treatment Programme commenced in the Ga-West and Ga-South municipalities of the Greater Accra region of Ghana. |
| March 2009 | Cotonou declaration adopted in Cotonou, Benin, by the WHO Director-General, Minister of health, Ghana, other West African presidents and participants, to take all the necessary measures to alleviate the suffering caused by Buruli ulcer, and to contribute to further enhancement of knowledge about the disease. |
Patient characteristics and clinical forms of Buruli ulcer (2005–2008).
| Yearly periods | |||
| 2005–2006 (%) | 2006–2007(%) | 2007–2008 (%) | |
| N = 99 | N = 85 | N = 113 | |
|
| |||
|
| |||
| Less than 15years | 56 (56.6) | 40 (47.1) | 50 (44.2) |
| 15–49 | 38 (38.4) | 38 (44.7) | 52 (46.0) |
| Above 49 years | 5 (5.1) | 7 (8.2) | 11 (9.7) |
|
| |||
| Male | 41 (41.4) | 41 (48.2) | 62 (54.9) |
| Female | 58 (58.6) | 44 (51.8) | 51 (45.1) |
|
| |||
| Nodule | 22 (22.2) | 3 (3.5) | 18 (16.0) |
| Plaque | 22 (22.2) | 11 (13.0) | 10 (8.8) |
| Oedema | 2 (2.0) | 7 (8.1) | 7 (6.2) |
| Ulcer | 52 (52.5) | 62 (73.0) | 67 (59.3) |
| Mixed | 1 (1.0) | 2 (2.4) | 10 (8.8) |
| Osteomyelitis | 0 (0.0) | 0 (0.0) | 1 (0.9) |
|
| |||
| New | 85 (86.0) | 85 (100.0) | 113 (100.0) |
| Recurrent | 14 (14) | 0 (0.0) | 0 (0.0) |
|
| |||
| Yes | 15 (15.2) | 19 (22.4) | 28 (24.8) |
| No | 84 (84.8) | 66 (77.6) | 85 (75.2) |
Source: Patient data 2005–2008, Amasaman hospital.
*Since the BUPaT programme was initiated in June 2005, a yearly period was calculated from June to May the next year.
Treatment types, outcomes and surgical procedures for Buruli ulcer patients (2005–2008).
| Yearly periods | |||
| 2005–2006 (%) | 2006–2007 (%) | 2007–2008 N (%) | |
| N = 99 | N = 85 | N = 113 | |
|
| |||
| Limitation present | 14 (14.0) | 19 (22.4) | 32 (28.3) |
| No limitation present | 85 (86.0) | 66 (77.6) | 81 (71.7) |
|
| |||
| Surgery only | 37 (37.4) | 4 (4.7) | 0 (0.0) |
| Antibiotics only | 35 (35.4) | 20 (23.5) | 48 (42.5) |
| Antibiotics and surgery | 27 (27.3) | 61 (71.8) | 65 (57.5) |
|
| |||
| Excision only | 24 (37.5) | 16 (24.6) | 33 (50.8) |
| Skin grafting | 36 (56.3) | 41 (63.1) | 28 (43.1) |
| Amputation | 1 (1.6 ) | 2 (3.1) | 2 (3.1) |
| Wound debridement | 3 (4.7) | 6 (9.2) | 2 (3.1) |
|
| |||
| Healed without deformity | 67 (67.7) | 53 (62.4) | 39 (34.5) |
| Referral | 13 (13.1) | 14 (16.5) | 6 (5.3) |
| Healed with deformity | 4 (4.0) | 9 (10.6) | 14 (12.4) |
| Absconded / lost to follow-up | 14 (14.1) | 8 (9.4) | 16 (14.2) |
| Died, Buruli ulcer related | 1 (1.0) | 1 (1.2) | 2 (1.8) |
| Still on admission | 0 (0.0) | 0 (0.0) | 36 (31.9) |
Source: Patient data 2005–2008, Amasaman hospital.
*Since the BUPaT programme was initiated in June 2005, a yearly period was calculated from June to May the next year.
**Surgical procedures explains treatment types for patients that had ‘surgery only’ and ‘antibiotics and surgery’.
Figure 1Resolution of Buruli ulcer using antibiotic treatment without surgery.